This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Luznik L, O’Donnell PV, Fuchs EJ . Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol 2012; 39: 683–693.
Munchel A, Kesserwan C, Symons HJ, Luznik L, Kasamon YL, Jones RJ et al. Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. Pediatr Rep 2011; 3 (Suppl 2): e15.
Zhang YY, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies. Bone Marrow Transplant 2014; 49: 496–501.
Chang YJ, Luznik L, Fuchs EJ, Huang XJ . How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? J Hematol Oncol 2016; 9: 35.
Tiercy JM . How to select the best available related or unrelated donor of hematopoietic stem cells? Haematologica 2016; 101: 680–687.
Kasamon YL, Ambinder RF, Fuchs EJ, Zahurak M, Rosner GL, Bolaños-Meade J et al. Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide. Blood Adv 2017; 1: 288–292.
Kawai T, Sachs DH, Sykes M, Cosimi AB . Immune tolerance network. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2013; 368: 1850–1852.
Acknowledgements
Author contributions
AG and PC wrote the paper. PC supervised the entire work. TGu, PP, YL, VD, BM, MCB, TGa, CT, NB, SL and PM critically revised the manuscript. All authors approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Garnier, A., Guillaume, T., Peterlin, P. et al. Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier. Bone Marrow Transplant 52, 1063–1064 (2017). https://doi.org/10.1038/bmt.2017.60
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.60
This article is cited by
-
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
Bone Marrow Transplantation (2022)